Latest / The Podcast by KevinMD

Aduhelm and how money and politics supersede science
"Sufferers of diseases, particularly terrible ones like Alzheimer's disease, and their loved ones need and deserve something better than science can deliver today. However, the scientific rigor of the clinical trials process where approval is only granted to drugs with a clear benefit in excess of risk needs to return.
Imagine the position this puts neurologists in today. Having a conversation with an Alzheimer's disease patient and family about why prescribing Aduhelm does not make sense. The only thing they would likely hear is they are being robbed of hope, false though it may be. And yet…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.